IMMUNOTECHNOLOGY CORP 4
4 · IMMUNOTECHNOLOGY CORP · Filed Sep 21, 2004
Insider Transaction Report
Form 4
SCHARMANN MARK A
Director
Transactions
- Sale
Common Stock
2004-09-16$0.05/sh−500,000$24,250→ 27,973,760 total
Holdings
- 7,250(indirect: Shares held by Troika Capital, Inc., an entity controlled by the Reporting Person)
Common Stock
- 337,500(indirect: By IRA)
Common Stock